Literature DB >> 29622226

Specific colorimetric ELISA method based on DNA hybridization reaction and non-crosslinking gold nanoparticles aggregation for the detection of amantadine.

Fang-Fei Zhu1, Juan Peng1, Zhen Huang1, Li-Ming Hu1, Gang-Gang Zhang1, Dao-Feng Liu2, Ke-Yu Xing1, Kai-Yi Zhang1, Wei-Hua Lai3.   

Abstract

Amantadine (AMD), a banned antiviral veterinary drug, is still being abused. This study developed a novel enzyme linked immunosorbent assay for the colorimetric detection of AMD involving DNA hybridization reaction and non-crosslinking gold nanoparticles (AuNPs) aggregation. Accordingly, the Primer 1-AuNPs-anti-AMD monoclonal antibody (mAb) could be captured by AMD artificial antigen on ELISA wells. Primer 2, which was complementary paired to Primer 1, was eventually added into the ELISA wells. After the hybridization reaction, the free Primer 2 in the supernatant was mixed with AuNPs and NaCl and induced a rapid color change of AuNPs. The lack of AMD in the sample resulted in capturing a substantial Primer 1-AuNPs-mAb complex and limited free Primer 2 in the supernatant. After adding NaCl, the color of AuNPs turned blue with limited Primer 2. This simple and visualized novel method had good sensitivity (0.033 μM) and exhibited a potential application for AMD screening on site.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AMD; AuNPs; DNA; ELISA

Mesh:

Substances:

Year:  2018        PMID: 29622226     DOI: 10.1016/j.foodchem.2018.03.033

Source DB:  PubMed          Journal:  Food Chem        ISSN: 0308-8146            Impact factor:   7.514


  2 in total

1.  Fluorometric determination of the CCAAT/enhancer binding protein alpha by using gold nanoparticles and a labeled protein-binding DNA.

Authors:  Jiehua Ma; Jinlong Li; Xianwei Cui; Lianghui You; Yun Li; Juan Wen; Chenbo Ji; Xirong Guo
Journal:  Mikrochim Acta       Date:  2019-12-05       Impact factor: 5.833

2.  Microfluidic fluorescent platform for rapid and visual detection of veterinary drugs.

Authors:  Ge Li; Hao Li; Jiang Zhai; Jiazhuang Guo; Qing Li; Cai-Feng Wang; Su Chen
Journal:  RSC Adv       Date:  2022-03-16       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.